SUSTAIN 6: A phase 3 study of semaglutide in subjects with type 2 diabetes
The decision-making process starts with a comprehensive medical history review, including the patients current health status, weight loss goals, and any existing medical conditions such as diabetes, heart disease, or hormonal imbalances
Chapter 4: Trial and Resolution 4.1 The Trial Process Each side presents their case, including witnesses and evidence
Patients in the phase 3b clinical trial maintained about 75-80% of their weight loss and health benefits, such as reduced waist circumference and improvements in blood pressure, blood sugar, triglycerides and cholesterol levels
Prescription medications such as Semaglutide, Tirzepatide, and oral Semaglutide are used under medical supervision to assist in weight management